|
|
Blood, 1 October 2007, Vol. 110, No. 7, pp. 2440-2448.
Prepublished online as a Blood First Edition Paper on May 29, 2007; DOI 10.1182/blood-2007-03-078709.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Endothelial progenitor cell–derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA
Maria Chiara Deregibus1,
Vincenzo Cantaluppi1,
Raffaele Calogero2,
Marco Lo Iacono2,
Ciro Tetta3,
Luigi Biancone1,
Stefania Bruno1,
Benedetta Bussolati1, and
Giovanni Camussi1
1 Department of Internal Medicine, Research Center for Experimental Medicine (CeRMS) and Center for Molecular Biotechnology, Torino, Italy;
2 Department of Clinical and Biologic Sciences, University of Torino, Torino, Italy;
3 Fresenius Medical Care, Bad Homburg, Germany
Membrane-derived microvesicles (MVs) are released from the cell surface and are implicated in cell-to-cell communication. We evaluated whether MVs derived from endothelial progenitor cells (EPCs) are able to trigger angiogenesis. We found that EPC-derived MVs were incorporated in endothelial cells by interaction with 4 and ß1 integrins expressed on the MV surface. In vitro, MVs promoted endothelial cell survival, proliferation, and organization in capillary-like structures. In vivo, in severe combined immunodeficient (SCID) mice, MV-stimulated human endothelial cells organized in patent vessels. When incubated with RNase, despite their internalization into endothelial cells, MVs failed to induce in vitro and in vivo angiogenic effects. mRNA transfer was shown by transduction of GFP protein in endothelial cells by MVs containing GFP-mRNA and the biologic relevance by the angiogenic effect of MV-mRNA extract delivered by lipofectamine. Microarray ana-lysis and quantitative reverse transcription–polymerase chain reaction (RT-PCR) of MV-mRNA extract indicated that MVs were shuttling a specific subset of cellular mRNA, such as mRNA associated with the PI3K/AKT signaling pathway. Protein expression and functional studies showed that PI3K and eNOS play a critical role in the angiogenic effect of MVs. These results suggest that EPCs may activate angiogenesis in endothelial cells by releasing MVs able to trigger an angiogenic program.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Trading places: mRNA transfer between cells
- Andrew S. Weyrich, Larry W. Kraiss, and Guy A. Zimmerman
Blood 2007 110: 2219.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. Obregon, B. Rothen-Rutishauser, P. Gerber, P. Gehr, and L. P. Nicod
Active Uptake of Dendritic Cell-Derived Exovesicles by Epithelial Cells Induces the Release of Inflammatory Mediators through a TNF-{alpha}-Mediated Pathway
Am. J. Pathol.,
August 1, 2009;
175(2):
696 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Prokopi, G. Pula, U. Mayr, C. Devue, J. Gallagher, Q. Xiao, C. M. Boulanger, N. Westwood, C. Urbich, J. Willeit, et al.
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures
Blood,
July 16, 2009;
114(3):
723 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Bonventre
Microvesicles from Mesenchymal Stromal Cells Protect against Acute Kidney Injury
J. Am. Soc. Nephrol.,
May 1, 2009;
20(5):
927 - 928.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bruno, C. Grange, M. C. Deregibus, R. A. Calogero, S. Saviozzi, F. Collino, L. Morando, A. Busca, M. Falda, B. Bussolati, et al.
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
J. Am. Soc. Nephrol.,
May 1, 2009;
20(5):
1053 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Flaumenhaft, J. R. Dilks, J. Richardson, E. Alden, S. R. Patel-Hett, E. Battinelli, G. L. Klement, M. Sola-Visner, and J. E. Italiano Jr
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles
Blood,
January 29, 2009;
113(5):
1112 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Khatua, H. E. Taylor, J. E. K. Hildreth, and W. Popik
Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells
J. Virol.,
January 15, 2009;
83(2):
512 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Majka, M. Skokan, L. Wheeler, J. Harral, S. Gladson, E. Burnham, J. E. Loyd, K. R. Stenmark, M. Varella-Garcia, and J. West
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol,
December 1, 2008;
295(6):
L1028 - L1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino
Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction
Therapeutic Advances in Cardiovascular Disease,
October 1, 2008;
2(5):
329 - 339.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Wakefield, D. D. Myers, and P. K. Henke
Mechanisms of Venous Thrombosis and Resolution
Arterioscler Thromb Vasc Biol,
March 1, 2008;
28(3):
387 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|